ENSYSCE BIOSCIENCES, INC. Debt Instrument, Decrease, Forgiveness
ENSYSCE BIOSCIENCES, INC. (ENSC) reported Debt Instrument, Decrease, Forgiveness of $3.30 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-15.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentDecreaseForgiveness · last filed 2021-03-15
- ENSYSCE BIOSCIENCES, INC. debt instrument, decrease, forgiveness for the quarter ending 2020-12-31 was $0.00.
- ENSYSCE BIOSCIENCES, INC. debt instrument, decrease, forgiveness for the quarter ending 2020-09-30 was $0.00.
- ENSYSCE BIOSCIENCES, INC. debt instrument, decrease, forgiveness for fiscal 2020 was $3.30M.
| Period end | Debt Instrument, Decrease, Forgiveness 3 month | Debt Instrument, Decrease, Forgiveness 6 month | Debt Instrument, Decrease, Forgiveness 9 month | Debt Instrument, Decrease, Forgiveness 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $0.00 derived: sum of 2 quarters · filed 2021-03-15 | $3.30M 10-K · filed 2021-03-15 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.30M 10-Q · filed 2020-11-09 | ||
| 2020-06-30 | $3.30M 10-Q · filed 2020-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |